Cita APA (7a ed.)

N, T., A, M., A, C., M, R., V, B., MM, K., & HA, S. (2020). Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]. Dove Medical Press.

Cita Chicago Style (17a ed.)

N, Tahir, Madni A, Correia A, Rehman M, Balasubramanian V, Khan MM, y Santos HA. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]. Dove Medical Press, 2020.

Cita MLA (8a ed.)

N, Tahir, et al. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]. Dove Medical Press, 2020.